141 related articles for article (PubMed ID: 35856859)
1. Provider Mistrust and Telemedicine Abortion Care Preferences Among Patients in Ohio, West Virginia, and Kentucky.
Rivlin K; Brenner-Levoy J; Odum T; Muzyczka Z; Norris A; Norris Turner A; Bessett D
Telemed J E Health; 2023 Mar; 29(3):414-424. PubMed ID: 35856859
[No Abstract] [Full Text] [Related]
2. Federal, state, and institutional barriers to the expansion of medication and telemedicine abortion services in Ohio, Kentucky, and West Virginia during the COVID-19 pandemic.
Mello K; Smith MH; Hill BJ; Chakraborty P; Rivlin K; Bessett D; Norris AH; McGowan ML
Contraception; 2021 Jul; 104(1):111-116. PubMed ID: 33930382
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and abortion in the Ohio River Valley: A case study of Kentucky, Ohio, and West Virginia.
Smith MH; Broscoe M; Chakraborty P; Hill J; Hood R; McGowan M; Bessett D; Norris AH
Perspect Sex Reprod Health; 2023 Sep; 55(3):178-191. PubMed ID: 37571959
[TBL] [Abstract][Full Text] [Related]
4. Determinants of women's preferred and actual abortion provision locations in Nigeria.
Byrne ME; Omoluabi E; OlaOlorun FM; Moreau C; Bell SO
Reprod Health; 2021 Nov; 18(1):240. PubMed ID: 34838089
[TBL] [Abstract][Full Text] [Related]
5. Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S.
Anger HA; Raymond EG; Grant M; Haskell S; Boraas C; Tocce K; Banks J; Coplon L; Shochet T; Platais I; Winikoff B
Contraception; 2021 Dec; 104(6):659-665. PubMed ID: 34329607
[TBL] [Abstract][Full Text] [Related]
6. Illinois, Massachusetts: governors veto restrictions on state funds for abortion.
Fam Plann Popul Rep; 1977 Oct; 6(5):57-9. PubMed ID: 12308832
[TBL] [Abstract][Full Text] [Related]
7. "It was close enough, but it wasn't close enough": A qualitative exploration of the impact of direct-to-patient telemedicine abortion on access to abortion care.
Kerestes C; Delafield R; Elia J; Chong E; Kaneshiro B; Soon R
Contraception; 2021 Jul; 104(1):67-72. PubMed ID: 33933421
[TBL] [Abstract][Full Text] [Related]
8. Abortion Clients' Perceptions of Alternative Medication Abortion Service Delivery Options in Mississippi.
Lerma K; Arey W; Strelitz-Block E; Nathan S; White K
Womens Health Issues; 2024; 34(2):156-163. PubMed ID: 38151449
[TBL] [Abstract][Full Text] [Related]
9. Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks' gestation at British Pregnancy Advisory Service: A cross-sectional evaluation.
Meurice ME; Whitehouse KC; Blaylock R; Chang JJ; Lohr PA
Contraception; 2021 Jul; 104(1):61-66. PubMed ID: 33974918
[TBL] [Abstract][Full Text] [Related]
10. Medication Abortion Provided Through Telemedicine in Four U.S. States.
Kohn JE; Snow JL; Simons HR; Seymour JW; Thompson TA; Grossman D
Obstet Gynecol; 2019 Aug; 134(2):343-350. PubMed ID: 31306317
[TBL] [Abstract][Full Text] [Related]
11. Medication abortion via digital health in the United States: a systematic scoping review.
Kumsa FA; Prasad R; Shaban-Nejad A
NPJ Digit Med; 2023 Jul; 6(1):128. PubMed ID: 37438435
[TBL] [Abstract][Full Text] [Related]
12. The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic.
Ennis M; Wahl K; Jeong D; Knight K; Renner R; Munro S; Dunn S; Guilbert E; Norman WV
Fam Pract; 2021 Aug; 38(Suppl 1):i30-i36. PubMed ID: 34448482
[TBL] [Abstract][Full Text] [Related]
13. Determinants of demand: method selection and provider preference among US women seeking abortion services.
Shochet T; Trussell J
Contraception; 2008 Jun; 77(6):397-404. PubMed ID: 18477487
[TBL] [Abstract][Full Text] [Related]
14. Factors Associated With Use of an Online Telemedicine Service to Access Self-managed Medical Abortion in the US.
Aiken ARA; Starling JE; Gomperts R
JAMA Netw Open; 2021 May; 4(5):e2111852. PubMed ID: 34019085
[TBL] [Abstract][Full Text] [Related]
15. Telemedicine for medical abortion service provision in Mexico: A safety, feasibility, and acceptability study.
Peña M; Figueroa Flores K; Muñoz Ponce M; Facio Serafín D; Camarillo Zavala AM; Ruiz Cruz C; Ortiz Salgado IG; Ochoa Rosado Y; Socarras T; Pacheco López A; Bousiéguez M
Contraception; 2022 Oct; 114():67-73. PubMed ID: 35753406
[TBL] [Abstract][Full Text] [Related]
16. Exploring provider preference and provision of abortion methods and stigma: Secondary analysis of a United Kingdom provider survey.
Footman K; Bright S; Kavanagh J; Parnham E; Bury L; Hoggart L
Perspect Sex Reprod Health; 2024 Mar; 56(1):50-59. PubMed ID: 38456347
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study.
Upadhyay UD; Johns NE; Combellick SL; Kohn JE; Keder LM; Roberts SC
PLoS Med; 2016 Aug; 13(8):e1002110. PubMed ID: 27575488
[TBL] [Abstract][Full Text] [Related]
18. Medication Abortion With Pharmacist Dispensing of Mifepristone.
Grossman D; Baba CF; Kaller S; Biggs MA; Raifman S; Gurazada T; Rafie S; Averbach S; Meckstroth KR; Micks EA; Berry E; Raine-Bennett TR; Creinin MD
Obstet Gynecol; 2021 Apr; 137(4):613-622. PubMed ID: 33706339
[TBL] [Abstract][Full Text] [Related]
19. Demand for Self-Managed Medication Abortion Through an Online Telemedicine Service in the United States.
Aiken ARA; Starling JE; van der Wal A; van der Vliet S; Broussard K; Johnson DM; Padron E; Gomperts R; Scott JG
Am J Public Health; 2020 Jan; 110(1):90-97. PubMed ID: 31622157
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
